ONWARD Medical Publishes Q3 2026 Results Presentation

By Public Technologies
  • ONWARD Medical reported revenue of €2.5 million for the third quarter of 2026.
  • ARCEX systems sold or supplied through paid evaluations totaled 88, up 120% year over year.
  • Net cash stood at €73.4 million on September 30, 2026; quarterly cash burn totaled €8.1 million.
  • Commercial reach exceeded 170 clinics worldwide, including more than 150 US clinics and Veterans Affairs facilities.
  • The Empower BP pivotal trial had enrolled 31 participants, with 16 clinical sites actively recruiting as of November 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ONWARD Medical NV published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.